Joint development of a new drug targeting pancreatic cancer
A press release from the Japan Agency for Medical Research and Development (AMED):
Joint development of a new drug targeting pancreatic cancer―cooperation regarding next-generation drug development technology using cancer-absorbing peptides to fight refractory cancer
